News search

TARGET-DC, CNIC initiative led by Dr. David Sancho aims to identify novel immune checkpoints in dendritic cells to advance T-cell activation.

The initiative will combine innovative medical and digital technologies to improve the early detection of cardiac risk and complications in cancer patients and survivors 

The Young Author Achievement Award recognises her research into cardiotoxicity published in JACC: Cardio-Oncology

A new CNIC-led study shows that a genetic tool derived from baker’s yeast enables human cells to manufacture the building blocks of DNA even when their mitochondria fail.

The study, published in Circulation Research, identifies cardiac fibroblasts and resident macrophages as essential contributors to the characteristic electrical activity that maintains this arrhythmia

A prespecified landmark analysis of the REBOOT trial, published in The European Heart Journal Cardiovascular Pharmacotherapy, shows no clinical benefit of beta-blockers during the first year after infarction or beyond one year, in patients without reduced ejection fraction.

A team from the CNIC and Hospital Clínico Universitario de Valladolid has developed a minimally invasive, catheter-based procedure to treat defective mechanical aortic valves

A CNIC research team has identified for the first time the biological mechanism underlying this susceptibility: high blood pressure creates a hidden metabolic vulnerability in the heart that becomes destabilized when anthracyclines are administered.